| Title | Tobacco addiction. | | Author(s) | Hatsukami DK, Stead LF, Gupta PC | | Institution | University of Minnesota, Comprehensive Cancer Center and Psychiatry, Minneapolis, Minnesota, USA. hatsu001@umn.edu | | Source | Lancet 2008 Jun 14; 371(9629):2027-38. | | MeSH | Counseling
Female
Humans
Male
Nicotine
Nicotinic Agonists
Physician's Role
Prevalence
Smoking
Smoking Cessation
Tobacco Use Disorder
| | Abstract | Tobacco use is associated with 5 million deaths per year worldwide and is regarded as one of the leading causes of premature death. Comprehensive programmes for tobacco control can substantially reduce the frequency of tobacco use. An important component of a comprehensive programme is the provision of treatment for tobacco addiction. Treatment involves targeting several aspects of addiction including the underlying neurobiology and behavioural processes. Furthermore, building an infrastructure in health systems that encourages and helps with cessation, as well as expansion of the accessibility of treatments, is necessary. Although pharmacological and behavioural treatments are effective in improving cessation success, the rate of relapse to smoking remains high, emphasising the strong addictive nature of nicotine. The future of treatment resides in improvement in patient matching to treatment, combination or novel drugs, and viewing nicotine addiction as a chronic disorder that might need long-term treatment. | | Language | eng | | Pub Type(s) | Journal Article
Research Support, Non-U.S. Gov't
Review
| | PubMed ID | 18555914 |
|
